Artificial Intelligence to Measure Adherence to Oral Medication
ConditionFirst Episode Psychosis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age15-40
SponsorNorthwell Health
About this trial
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Enrolled in a CSC program
Prescribed an oral antipsychotic
Disqualifiers
none
Trial design
Design model
Parallel
Treatments tested in this trial
Smartphone App
Other interventionartificial intelligence (AI) smartphone app to provide support for medication adherence
Usual Care
Other interventionUsual Care provided by CSC clinic
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Smartphone AppExperimental treatment 1 intervention
Group B: Usual CareActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Service Utilization Report Form
Provides participant utilization of psychiatric ER visits or psychiatric hospitalization
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Northwell Health
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov